Skip to main content

Table 1 Group characteristics

From: Advanced glycation endproducts and their receptor in different body compartments in COPD

 

Young healthy

Old healthy

COPD

 

n = 108

n = 83

n = 97

Age, years

25 (66)

54 (8.9)

62 (7.6)

Males, n (%)

54 (50)

60 (72)

68 (70)

Current smokers, n (%)

72 (67)

54 (65)

51 (53)

Cigarettes per day

9 (6.8)

16 (7.1)

11 (7.9)

Packyears

3.1 (4.8)

20 (18.0)

38 (16.8)

BMI, kg/m2

23.0 (2.8)

25.3 (3.6)

25.5 (4.7)

FEV1, %pred

108 (9.5)

110 (13.5)

62 (27)

FEV1/FVC, %

85 (5.7)

79 (5.0)

48 (14)

RV/TLC, %

23.3 (5.1)

31.1 (4.4)

45.8 (11.3)

FEF25-75, %pred

101 (18.7)

100 (30.4)

24 (17)

DLCOc/VA, %pred

97 (13.3)

98 (12.6)

67 (24)

DLCO %pred

91.6 (12.0)

90.0 (12.3)

61.6 (23.6)

LDL cholesterol, mmol/L

2.6 (0.8)

3.6 (1.0

3.4 (1.0)

Triglycerides, mmol/L

1.0 (0.8)

1.4 (1.0)

1.2 (0.7)

Fasting glucose, mmol/L

5.2 (1.3)

5.6 (0.7)

5.8 (0.7)

Creatinine, μmol/L

73.7 (10.9)

80.2 (14.5)

82.7 (14.8)

  1. Data is presented as mean (sd) unless otherwise stated
  2. n number, BMI body mass index, FEV 1 forced expiratory volume in one second, FVC forced expiratory volume, RV residual volume, TLC total lung capacity, FEF forced expiratory flow, DLCO( c /VA) diffusion coefficient for carbon monoxide, LDL low density lipoprotein